Pharmacology of the Respiratory, Gastrointestinal and Genitourinary Drugs: Clinical Implications
COURSE NUMBER: 540
Geza T. Terezhalmy, DDS, MA
Credit Hours:
2 Hour(s)
SHARE
The objectives of the course are to identify therapeutic agents commonly prescribed for the treatment of respiratory, gastrointestinal, and genitourinary disorders, present their mechanisms of action, discuss indications for their use, and ...
(Use this feature to create assignments for your students and staff.)
Overview
The objectives of the course are to identify therapeutic agents commonly prescribed for the treatment of respiratory, gastrointestinal, and genitourinary disorders, present their mechanisms of action, discuss indications for their use, and correlate the information to clinical dentistry.
This continuing dental education course is intended to provide a clinical frame of reference when patients present in the oral healthcare setting with a history of taking drugs for the treatment of respiratory, gastrointestinal (GI), and genitourinary (GU) disorders. Based on the Top 300 Prescription Drugs dispensed by U.S. community pharmacies, common respiratory, GI, and GU disorders are identified and discussed, including implications to clinical dentistry.
Intended Audience:
Dentists, Dental Hygienists, Dental Assistants, Dental Students, Dental Hygiene Students, Dental Assisting Students
Date Course Online:
Jan 2, 2018
Last Revision Date:
NA
Course Expiration Date:
Oct 31, 2019
Cost:
Free
Method:
Self-instructional
AGD Subject Code(s):
10
Technical Requirements:
Stable internet connection and the latest version of browser and device software are recommended.
Learning Objectives
Upon completion of this course, the dental professional should be able to:
- Discuss the relevance of the top 300 drugs dispensed by U.S. community pharmacies.
- Identify common respiratory, gastrointestinal, and genitourinary drugs.
- Discuss the mechanism of action of respiratory, gastrointestinal, and genitourinary drugs and indications for their use.
- Discuss prevalent respiratory, gastrointestinal, and genitourinary disorders with reference to the practice of dentistry.
Disclaimers
P&G is providing these resource materials to dental professionals. We do not own this content nor are we responsible for any material herein. Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice. Only sound evidence-based dentistry should be used in patient therapy. Note: Registration is required to take test.
Submission Information
Academy of General Dentistry (AGD) Submission For credit transfers to appear in your AGD account in real time, make sure to add your AGD membership number in the field provided on the “Share Your Test Score” page.
CE Broker For all states that use CE Broker for licensure, “proof of completions” are electronically reported the first of every month. If a course was taken in November, the “proof of completion” will be submitted the beginning of December.
Recognition
Approved PACE Program Provider
THE PROCTER & GAMBLE COMPANY
Nationally Approved PACE Program Provider for FAGD/MAGD credit.
Approval does not imply acceptance by any regulatory authority or AGD endorsement.
8/1/2021 to 7/31/2027
Provider ID# 211886
AADH Approved Program Provider
Procter & Gamble is designated as an approved Provider by the American Academy of Dental Hygiene, Inc. #AADHPGC (January 1, 2024-December 31, 2025). Approval does not imply acceptance by a state or provincial Board of Dentistry. Licensee should maintain this document in the event of an audit.
(Use this feature to create assignments for your students and staff.)